The (CAG)n tract of Machado-Joseph Disease gene (ATXN3): A comparison between DNA and mRNA in patients and controls

European Journal of Human Genetics

Volumn 18, Issue 5, 2010, Pages 621-623

  Bettencourt, Conceiço ^a,b   Santos, Cristina ^a,c   Montiel, Rafael ^d   Kay, Teresa ^e   Vasconcelos, Joo ^f   MacIel, Patrícia ^g   Lima, Manuela ^a,b  

^a UNIVERSITY OF THE AZORES   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d DEPARTAMENTO DE FÍSICA   (Mexico)

^e HOSPITAL DONA ESTEFÂNIA   (Portugal)

^f HOSPITAL DO DIVINO ESPÍRITO SANTO   (Portugal)

^g UNIVERSITY OF MINHO   (Portugal)

Author keywords

CAG repeats; MJD; Polyglutamine disorders; SCA3; Transcript variation

Indexed keywords

ATAXIN 3; COMPLEMENTARY DNA; DNA; GENOMIC DNA; MESSENGER RNA;

ALLELE; ARTICLE; CAG REPEAT; CHROMOSOME 14Q; CONTROLLED STUDY; EXON; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MACHADO JOSEPH DISEASE; MAJOR CLINICAL STUDY; ONSET AGE; PRIORITY JOURNAL; WILD TYPE;

ADULT; ALLELES; CASE-CONTROL STUDIES; DNA; GENE EXPRESSION REGULATION; HUMANS; MACHADO-JOSEPH DISEASE; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; REPRESSOR PROTEINS; RNA, MESSENGER; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 77951621418     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2009.215     Document Type: Article

References (16)

1. Schols L, Bauer P, Schmidt T, Schulte T, Riess O: Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol 2004; 3: 291-304.
2. Bettencourt C, Santos C, Kay T, Vasconcelos J, Lima M: Analysis of segregation patterns in Machado-Joseph disease pedigrees. J Hum Genet 2008; 53: 920-923.
3. Coutinho P, Andrade C: Autosomal dominant system degeneration in Portuguese families of the Azores Islands. A new genetic disorder involving cerebellar, pyramidal, extrapyramidal and spinal cord motor functions. Neurology 1978; 28: 703-709.
4. Kawaguchi Y, Okamoto T, Taniwaki M et al: CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat Genet 1994; 8: 221-228.
5. Ichikawa Y, Goto J, Hattori M et al: The genomic structure and expression of MJD, the Machado-Joseph disease gene. J Hum Genet 2001; 46: 413-422.
6. Maciel P, Costa MC, Ferro A et al: Improvement in the molecular diagnosis of Machado-Joseph disease. Arch Neurol 2001; 58: 1821-1827.
7. van Alfen N, Sinke RJ, Zwarts MJ et al: Intermediate CAG repeat lengths (53,54) for MJD/SCA3 are associated with an abnormal phenotype. Ann Neurol 2001; 49: 805-807.
8. Maciel P, Gaspar C, DeStefano AL et al: Correlation between CAG repeat length and clinical features in Machado-Joseph disease. Am J Hum Genet 1995; 57: 54-61.
9. Maruyama H, Nakamura S, Matsuyama Z et al: Molecular features of the CAG repeats and clinical manifestation of Machado-Joseph disease. Hum Mol Genet 1995; 4: 807-812.
10. Lopes-Cendes I, Maciel P, Kish S et al: Somatic mosaicism in the central nervous system in spinocerebellar ataxia type 1 and Machado-Joseph disease. Ann Neurol 1996; 40: 199-206.
11. Fabre E, Dujon B, Richard G-F: Transcript and nuclear transport of CAG/CTG trinucleotide repeats in yeast. Nucleic Acids Res 2002; 30: 3540-3547.
12. Bettencourt C, Fialho RN, Santos C et al: Segregation distortion of wild-type alleles at the Machado-Joseph disease locus: a study in normal families from the Azores islands (Portugal). J Hum Genet 2008; 53: 333-339.
13. SPSS Inc.: SPSS for Windows: Release 15. Chicago: SPSS Inc., 2006.
14. Raymond M, Rousset F: GENEPOP (version 1.2): population genetics software for exact tests and ecumenicism. J Heredity 1995; 86: 248-249.
15. Sinden RR, Potaman VN, Oussatcheva EA, Pearson CE, Lyubchenko YL, Shlyakhtenko LS: Triplet repeat DNA structures and human genetic disease: dynamic mutations from dynamic DNA. J Biosci 2002; 27 (Suppl 1): 53-65.
16. Ito Y, Tanaka F, Yamamoto M et al: Somatic mosaicism of the expanded CAG trinucleotide repeat in mRNAs for the responsible gene of Machado-Joseph disease (MJD), dentatorubral-pallidoluysian atrophy (DRPLA), and spinal and bulbar muscular atrophy (SBMA). Neurochem Res 1998; 23: 25-32.